妊娠期母体炎症蛋白与10岁时神经发育障碍
该研究为丹麦哥本哈根2010年哮喘前瞻性研究母婴出生队列的10年随访,检测妊娠第24周血浆92种炎症蛋白,评估子代10岁时神经发育障碍与执行功能。主成分分析显示母体炎症蛋白水平较高与任何神经发育障碍风险升高相关,尤其孤独症和注意缺陷多动障碍(ADHD)注意力缺陷为主型,执行功能未见关联。
要点
- 妊娠第24周母体炎症蛋白主成分1水平较高与子代10岁时任何神经发育障碍风险升高相关(OR 1.49)。
- 该主成分与孤独症(OR 2.76)及ADHD注意力缺陷为主型(OR 1.57)风险升高相关。
- 92种蛋白中18种达FDR 5%显著性,执行功能经FDR校正后无关联。
核心结论
- 妊娠期母体炎症蛋白组与子代10岁时神经发育障碍风险相关。
- 作者认为需进一步研究阐明妊娠期这些蛋白涉及的具体通路,以期通过预防策略降低儿童神经发育障碍风险。
研究设计与样本
- 丹麦哥本哈根2010年哮喘前瞻性研究母婴出生队列的10年随访研究。
- 采用妊娠第24周采集的血浆样本检测92种炎症蛋白。
- 子代神经发育障碍与执行功能于2019年1月至2021年12月(10岁时)评估。
- 纳入有妊娠期母体产前炎症蛋白及随访时子代神经发育障碍精神病理数据的母婴对。
- 数据分析于2023年12月至2024年8月进行。
主要发现
- 共纳入555名母亲(平均[SD]年龄32.4[4.3]岁)及其子女(285名男性[51%])。
- 主成分分析显示主成分1所代表的母体炎症蛋白水平较高与任何神经发育障碍风险升高相关(OR 1.49;95%CI 1.15-1.94;P=.003)。
- 主成分1与孤独症风险升高相关(OR 2.76;95%CI 1.45-5.63;P=.003)。
- 主成分1与ADHD注意力缺陷为主型风险升高相关(OR 1.57;95%CI 1.05-2.39;P=.03)。
- 单蛋白分析显示92种蛋白中18种经校正后达FDR 5%显著性;血管内皮生长因子A、C-C基序趋化因子配体、CD5、白细胞介素12B、成纤维细胞生长因子-23和单核细胞趋化蛋白-1为与神经发育障碍风险相关的首要蛋白。
关键数值与推荐
- 主成分1每升高一个单位,任何神经发育障碍风险OR 1.49(95%CI 1.15-1.94;P=.003)。
- 主成分1每升高一个单位,孤独症风险OR 2.76(95%CI 1.45-5.63;P=.003)。
- 主成分1每升高一个单位,ADHD注意力缺陷为主型风险OR 1.57(95%CI 1.05-2.39;P=.03)。
- 单蛋白分析以FDR 5%为显著性阈值,92种蛋白中18种达到该阈值。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 作者指出需进一步研究以阐明妊娠期这些蛋白涉及的具体通路。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Maternal inflammation during pregnancy has been associated with an increased risk of neurodevelopmental disorders (NDDs), such as attention-deficit/hyperactivity disorder (ADHD) and autism, and cognitive deficits in early childhood. However, little is known about the contributions of a wider range of inflammatory proteins to this risk. OBJECTIVE: To determine whether maternal inflammatory proteins during pregnancy are associated with the risk of NDDs and executive functions (EF) in middle childhood and to identify protein patterns associated with NDDs and EF. DESIGN, SETTING, AND PARTICIPANTS: This was a 10-year follow-up cohort study of the Danish Copenhagen Prospective Studies on Asthma 2010 mother-child birth cohort, using plasma samples collected at week 24 in pregnancy, where 92 inflammatory proteins were assessed. NDDs and EF were assessed in the offspring at age 10 years, between January 2019 and December 2021. Mother-offspring dyads with available maternal prenatal inflammatory proteins during pregnancy and offspring NDD psychopathology data at follow-up were included. Data analyses took place between December 2023 and August 2024. EXPOSURES: Levels of 92 inflammatory proteins from panel collected at week 24 during pregnancy. MAIN OUTCOMES AND MEASURES: Categorical and dimensional psychopathology of NDDs (primary outcome) and EF (secondary outcome). RESULTS: A total of 555 mothers (mean [SD] age, 32.4 [4.3] years) and their children (285 male [51%]) were included. The principal component analysis showed that higher levels of maternal inflammatory proteins depicted in principal component 1 were associated with a higher risk of any NDD (OR, 1.49; 95% CI, 1.15-1.94; P = .003), particularly autism (OR, 2.76; 95% CI, 1.45-5.63; P = .003) and ADHD with predominantly inattentive presentation (OR, 1.57; 95% CI, 1.05-2.39; P = .03). The single protein analysis showed that 18 of 92 proteins reached false discovery rate (FDR) 5% significance after adjustment. Vascular endothelial growth factor A, C-C motif chemokine ligand, CD5, interleukin 12B, fibroblast growth factor-23, and monocyte chemoattractant protein-1 emerged as top proteins associated with risk of NDDs. The sparse partial least squares approach identified 34 proteins associated with any NDD, and 39 with ADHD with predominantly inattentive presentation. There were no associations with EF after FDR correction. CONCLUSIONS AND RELEVANCE: The maternal inflammatory proteome during pregnancy was associated with NDDs risks in offspring at age 10 years. Further research is warranted to elucidate the specific pathways involving these proteins during pregnancy that could be targeted with prevention strategies to reduce risk of NDDs in children.
引用
- Wang T, Mohammadzadeh P, Jepsen JRM, et al. Maternal Inflammatory Proteins in Pregnancy and Neurodevelopmental Disorders at Age 10 Years. JAMA Psychiatry. 2025. PMID: 40072459. doi:10.1001/jamapsychiatry.2025.0122
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。